Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
The 2019 edition of the CAP accreditation checklists are now available. Some highlights of this edition’s changes include the addition of a new checklist requirement in the chemistry checklist on opiate testing, and the addition of a new checklist requirement in the transfusion medicine checklist to align with the FDA on the labeling of red blood cells with historical antigen typing.
New from Innovative Science Press is Survival Guide to Dermatopathology by Jerad M. Gardner, MD. Dr. Gardner covers many of the common entities in dermatopathology as well as some esoteric ones, particularly if they have distinct features or are of major clinical significance, in order to help the reader increase diagnostic confidence. The guide features numerous high-quality photomicrographs annotated with key findings.
Donald A. B. Lindberg, MD, former director of the National Library of Medicine, passed away on August 17. Past member of the CAP, Dr. Lindberg graduated from Columbia University College of Physicians and Surgeons in 1958 and was a professor of information science and professor of pathology at the University of Missouri-Columbia before being named director of the NLM in 1984. Read his New York Times obituary.
Executives at data analytics firm Diaceutics have written an article titled “Diagnostics reform and harmonization of clinical laboratory testing” in the Journal of Molecular Diagnostics.
Barbarajean (BJ) Magnani, PhD, MD, chief of clinical pathology and director of toxicology at Tufts Medical Center, has released her second book, a medical thriller featuring protagonist Dr. Lily Robinson.
George D. Lundberg, MD, addresses that question and more in a recent JAMA Network Open commentary to “Trends in the US and Canadian pathologist workforces from 2007 to 2017.”
The Cancer Biomarkers Conference series provides real-world practical updates for general community pathologists, molecular pathologists, oncologists, and related specialties and professions.
A white paper titled “Can Global Testing for C. difficile Carriers Help to Prevent Healthcare-associated CDI?” from Luminex discusses the results of two recent studies that show that performing C. difficile testing only in patients with clinically significant diarrhea may be missing an opportunity to prevent CDI transmission from asymptomatic carriers. Download the white paper.
A new white paper titled “The CMS National Coverage Decision on NGS” from Diaceutics provides coverage of ongoing developments since the NGS national coverage decision was made. Read the white paper (requires free registration).
In a collaborative effort to discuss the future of the laboratory in health care, Bob McGonnagle, publisher of CAP TODAY, gathered with Orchard Software’s Curt Johnson, chief operating officer, and Matt Modleski, chief operating officer, American Health Network.
